Global Type-1 Diabetes Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Type-1 Diabetes Treatment Market Overview

• 1.1 Product Overview and Scope of Type-1 Diabetes Treatment
• 1.2 Classification of Type-1 Diabetes Treatment by Types
  • 1.2.1 Global Type-1 Diabetes Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Type-1 Diabetes Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Rapid-Acting Insulin
  • 1.2.4 Short-Acting Insulin
  • 1.2.5 Others
• 1.3 Global Type-1 Diabetes Treatment Market by Application
  • 1.3.1 Global Type-1 Diabetes Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals & Clinics
  • 1.3.3 Academic & Research Institutes
• 1.4 Global Type-1 Diabetes Treatment Market by Regions
  • 1.4.1 Global Type-1 Diabetes Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Type-1 Diabetes Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Type-1 Diabetes Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Type-1 Diabetes Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Type-1 Diabetes Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Type-1 Diabetes Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Type-1 Diabetes Treatment (2014-2024)

2 Company Profiles

• 2.1 Astellas Pharma
  • 2.1.1 Business Overview
  • 2.1.2 Type-1 Diabetes Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Astellas Pharma Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Novartis
  • 2.2.1 Business Overview
  • 2.2.2 Type-1 Diabetes Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Novartis Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Novo Nordisk
  • 2.3.1 Business Overview
  • 2.3.2 Type-1 Diabetes Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Novo Nordisk Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Merck
  • 2.4.1 Business Overview
  • 2.4.2 Type-1 Diabetes Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Merck Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Boehringer Ingelheim GmbH
  • 2.5.1 Business Overview
  • 2.5.2 Type-1 Diabetes Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Eli Lilly
  • 2.6.1 Business Overview
  • 2.6.2 Type-1 Diabetes Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Eli Lilly Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Abbott Laboratories
  • 2.7.1 Business Overview
  • 2.7.2 Type-1 Diabetes Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Abbott Laboratories Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 AstraZeneca
  • 2.8.1 Business Overview
  • 2.8.2 Type-1 Diabetes Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 AstraZeneca Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Sanofi
  • 2.9.1 Business Overview
  • 2.9.2 Type-1 Diabetes Treatment Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Sanofi Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Pfizer Inc.
  • 2.10.1 Business Overview
  • 2.10.2 Type-1 Diabetes Treatment Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Pfizer Inc. Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Mannkind Corporation
  • 2.11.1 Business Overview
  • 2.11.2 Type-1 Diabetes Treatment Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Mannkind Corporation Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Braun Melsungen AG
  • 2.12.1 Business Overview
  • 2.12.2 Type-1 Diabetes Treatment Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Macrogenics, Inc.
  • 2.13.1 Business Overview
  • 2.13.2 Type-1 Diabetes Treatment Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Type-1 Diabetes Treatment Market Competition, by Players

• 3.1 Global Type-1 Diabetes Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Type-1 Diabetes Treatment Players Market Share
  • 3.2.2 Top 10 Type-1 Diabetes Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Type-1 Diabetes Treatment Market Size by Regions

• 4.1 Global Type-1 Diabetes Treatment Revenue and Market Share by Regions
• 4.2 North America Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)

5 North America Type-1 Diabetes Treatment Revenue by Countries

• 5.1 North America Type-1 Diabetes Treatment Revenue by Countries (2014-2019)
• 5.2 USA Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)

6 Europe Type-1 Diabetes Treatment Revenue by Countries

• 6.1 Europe Type-1 Diabetes Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Type-1 Diabetes Treatment Revenue by Countries

• 7.1 Asia-Pacific Type-1 Diabetes Treatment Revenue by Countries (2014-2019)
• 7.2 China Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)

8 South America Type-1 Diabetes Treatment Revenue by Countries

• 8.1 South America Type-1 Diabetes Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Type-1 Diabetes Treatment by Countries

• 9.1 Middle East and Africa Type-1 Diabetes Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Type-1 Diabetes Treatment Revenue and Growth Rate (2014-2019)

10 Global Type-1 Diabetes Treatment Market Segment by Type

• 10.1 Global Type-1 Diabetes Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Type-1 Diabetes Treatment Market Forecast by Type (2019-2024)
• 10.3 Rapid-Acting Insulin Revenue Growth Rate (2014-2024)
• 10.4 Short-Acting Insulin Revenue Growth Rate (2014-2024)
• 10.5 Others Revenue Growth Rate (2014-2024)

11 Global Type-1 Diabetes Treatment Market Segment by Application

• 11.1 Global Type-1 Diabetes Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Type-1 Diabetes Treatment Market Forecast by Application (2019-2024)
• 11.3 Hospitals & Clinics Revenue Growth (2014-2019)
• 11.4 Academic & Research Institutes Revenue Growth (2014-2019)

12 Global Type-1 Diabetes Treatment Market Size Forecast (2019-2024)

• 12.1 Global Type-1 Diabetes Treatment Market Size Forecast (2019-2024)
• 12.2 Global Type-1 Diabetes Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Type-1 Diabetes Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Type-1 Diabetes Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Type-1 Diabetes Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Type-1 Diabetes Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Type-1 Diabetes Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology